Drug Profile
Research programme: rheumatoid arthritis gene therapies - Amsterdam Molecular Therapeutics
Alternative Names: Research programme: rheumatoid arthritis gene therapies - AMT; Rheumatoid arthritis gene therapies research programme - AMTLatest Information Update: 16 Jul 2012
Price :
$50
*
At a glance
- Originator Amsterdam Molecular Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 24 Mar 2006 No development reported - Preclinical for Rheumatoid arthritis in Netherlands (unspecified route)
- 29 Oct 2004 Preclinical trials in Rheumatoid arthritis in Netherlands (unspecified route)